Page results
-
Initial results from an early phase study testing the safety and efficacy of a new drug for multiple myeloma have shown a 100 per cent overall response rate in patients with recurrent disease who were given the clinically recommended dose of the investigational drug.
-
The High Court has today (26 March) ruled that parents can consent on behalf of their child for hormone-blocking treatment in cases of gender dysphoria.
-
This two-part workshop is specially created for teenagers seeking to understand their anxiety more deeply and discover practical, effective strategies to manage it.
-
Learn more about how UCLH celebrated Research Open Day this month.
-
The world’s first COVID-19 vaccine study researching alternating doses and intervals of approved vaccines is taking place at UCLH.
-
UCLH is to work in partnership with University Hospitals Birmingham NHS Foundation Trust in a major digital health initiative in which researchers use data collected in acute care settings to improve patient care.
-
The spasticity team at The National Hospital for Neurology and Neurosurgery (NHNN) has produced a series of short animated videos. The films were funded by The National Brain Appeal, the charity dedicated to supporting NHNN.
-
This page tells you about the procedure known as a Bronchial Artery Embolisation (BAE).
-
UCLH has recruited the first European participant to a trial looking at treating non-hospitalised Covid-19 patients with the drug remdesivir.
-
This page provides information about the WEB device and how it is used to treat cerebral (brain) aneurysms
